| | |
 | | | What's Next for CBD? Former Cop Weighs In | | Matthew Carr | Chief Trends Strategist | The Oxford Club | | | | | Days before Thanksgiving, the Food and Drug Administration (FDA) threw cold water on the red-hot American CBD boom.
It stated that CBD could be "potentially harmful." And that more research needed to be done to determine its safety.
It was a frustrating moment for the industry.
That's because, each day, it seems the U.S. is falling behind in the knowledge gap on CBD.
Israel and China are doing extensive research into cannabis and CBD.
The World Health Organization has stated that "there is no evidence of... any public health-related problems associated with the use of pure CBD."
And even the National Institute on Drug Abuse deemed CBD a "safe drug with no addictive effects."
But the FDA appears to be ignoring these resources.
My guest today - Andy Snyder, founder of Manward Press - actually testified before the FDA earlier this year about the safety of CBD.
Andy offers a unique perspective on cannabis and the CBD market. He was in law enforcement. He's arrested people for marijuana.
But now he has a new mission. He's seeking to educate consumers about the potential benefits that CBD can offer.
We sat down to discuss why he got involved in CBD, his take on the FDA's decision and the issues facing hemp growers here in the U.S. Andy also shared what he wants to see at the federal level to bolster the industry and provide some much-needed research.
With the CBD market projected to be worth more than $20 billion over the next couple of years, this is an interview consumers and investors will want to check out.
Here's to high returns,
Matthew | | | | |  | | | | | |  |  | | | | David Fessler | December 18, 2019 Renewable energy - including EVs and charging - is my main investment focus for 2020. Read More | | | | |  | | | | Matthew Carr | December 17, 2019 The more than decade-old bull market transformed broader indexes and individual stocks into big-time winners. Read More | | | | |  | | | | Matthew Carr | December 16, 2019 Now that Canadian shelves are stuffed with all kinds of new cannabis products, what should investors really expect? Read More | | | | | | | | | | |
|
The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. 
No comments:
Post a Comment